Alveron Pharma DMF, CEP, Written Confirmations, FDF, Prices, Patents, Patents & Exclusivities, Dossier, Manufacturer, Licensing, Distributer, Suppliers, News

Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

Virtual Booth

Contact Supplier

Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

VISIT THE VIRTUAL BOOTH
Review portfolio & marketing content
CONTACT DETAILS
Google Map, LinkedIn, Emails...

DIGITAL CONTENT

1 News #PharmaBuzz

media
1 News #PharmaBuzz

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Alveron Pharma, founded in 2019, is a clinical-stage company developing OKL-1111, a first-line intravenous therapy for intracranial hemorrhage (ICH) associated with anticoagulant and/or platelet inhibitor use. OKL-1111's novel mechanism of action and product profile could enable a significant reduction in the time required to halt bleeding compared to other reversal approaches, aiming to limit hematoma expansion and improve clinical outcomes, including mortality and morbidity. Alveron recently completed a successful first-in-human trial of OKL-1111, marking a significant milestone in their mission to address this severe unmet